GEnetic Testing in Elective Single Embryo Transfer in Women of Advanced Maternal Age
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 35
Maximum Age: 40
Healthy Volunteers: f
View:
• Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
• Utilization of Intracytoplasmic Sperm Injection ICSI
• Utilization of ejaculated or testicular sperm
• Utilization of autologous or donor sperm
• All Controlled Ovarian Hyperstimulation (COH) protocols
Locations
United States
Florida
IVF Florida Reproductive Associates
RECRUITING
Margate
Contact Information
Primary
Nathan R Treff, PhD
nathan@genomicprediction.com
(973) 529-4223
Backup
Diego Marin, PhD
diego@genomicprediction.com
(973) 529-4223
Time Frame
Start Date: 2021-03-05
Estimated Completion Date: 2026-12
Participants
Target number of participants: 240
Treatments
Experimental: PGT-A transfer
Transfer of single chromosomally normal (euploid) blastocyst after PGT-A
No_intervention: Untested blastocyst transfer
Transfer of single untested blastocyst based on embryo morphology criteria.
Authors
Related Therapeutic Areas
Sponsors
Leads: Genomic Prediction Inc.